161 related articles for article (PubMed ID: 18454873)
1. Characterization of two functional NKX3.1 binding sites upstream of the PCAN1 gene that are involved in the positive regulation of PCAN1 gene transcription.
Liu W; Zhang P; Chen W; Yu C; Cui F; Kong F; Zhang J; Jiang A
BMC Mol Biol; 2008 May; 9():45. PubMed ID: 18454873
[TBL] [Abstract][Full Text] [Related]
2. Molecular cloning and analysis of the human PCAN1 (GDEP) promoter.
Liu W; Chen W; Zhang P; Yu C; Kong F; Deng J; Zhang J; Jiang A
Cell Mol Biol Lett; 2007; 12(4):482-92. PubMed ID: 17468839
[TBL] [Abstract][Full Text] [Related]
3. Identification of an inhibitory cis-element in the promoter region of human homeobox gene NKX3.1.
Anli J; Pengju Z; Xiaoyan H; Wenwei C; Zhifang L; Feng K; Huiqing Y; Jianye Z
Prostate; 2006 Sep; 66(12):1339-46. PubMed ID: 16845664
[TBL] [Abstract][Full Text] [Related]
4. Identification of Sp1-elements in the promoter region of human homeobox gene NKX3.1.
Yu CX; Jin T; Chen WW; Zhang PJ; Liu WW; Guan HY; Zhang J; Liu QW; Jiang AL
Mol Biol Rep; 2009 Nov; 36(8):2353-60. PubMed ID: 19263243
[TBL] [Abstract][Full Text] [Related]
5. Loss of the NKX3.1 tumorsuppressor promotes the TMPRSS2-ERG fusion gene expression in prostate cancer.
Thangapazham R; Saenz F; Katta S; Mohamed AA; Tan SH; Petrovics G; Srivastava S; Dobi A
BMC Cancer; 2014 Jan; 14():16. PubMed ID: 24418414
[TBL] [Abstract][Full Text] [Related]
6. Androgen regulation of the prostatic tumour suppressor NKX3.1 is mediated by its 3' untranslated region.
Thomas MA; Preece DM; Bentel JM
Biochem J; 2010 Jan; 425(3):575-83. PubMed ID: 19886863
[TBL] [Abstract][Full Text] [Related]
7. Transcriptional regulation of the homeobox gene NKX3.1 by all-trans retinoic acid in prostate cancer cells.
Thomas MA; Hodgson MC; Loermans SD; Hooper J; Endersby R; Bentel JM
J Cell Biochem; 2006 Dec; 99(5):1409-19. PubMed ID: 16817226
[TBL] [Abstract][Full Text] [Related]
8. Molecular cloning and characterization of human homeobox gene Nkx3.1 promoter.
Jiang AL; Zhang JY; Young C; Hu XY; Wang YM; Liu ZF; Hao ML
Acta Biochim Biophys Sin (Shanghai); 2004 Jan; 36(1):64-7. PubMed ID: 14732878
[TBL] [Abstract][Full Text] [Related]
9. Effects of 9-cis retinoic acid on human homeobox gene NKX3.1 expression in prostate cancer cell line LNCaP.
Jiang AL; Zhang PJ; Chen WW; Liu WW; Yu CX; Hu XY; Zhang XQ; Zhang JY
Asian J Androl; 2006 Jul; 8(4):435-41. PubMed ID: 16763719
[TBL] [Abstract][Full Text] [Related]
10. Up-regulation of NKX3.1 expression and inhibition of LNCaP cell proliferation induced by an inhibitory element decoy.
Jiang AL; Hu XY; Zhang PJ; He ML; Kong F; Liu ZF; Yuan HQ; Zhang JY
Acta Biochim Biophys Sin (Shanghai); 2005 May; 37(5):335-40. PubMed ID: 15880262
[TBL] [Abstract][Full Text] [Related]
11. Expression and initial promoter characterization of PCAN1 in retinal tissue and prostate cell lines.
Cross D; Reding DJ; Salzman SA; Zhang KQ; Catalona WJ; Burke J; Burmester JK
Med Oncol; 2004; 21(2):145-53. PubMed ID: 15299187
[TBL] [Abstract][Full Text] [Related]
12. An NKX3.1 binding site polymorphism in the l-plastin promoter leads to differential gene expression in human prostate cancer.
Chen C; Cai Q; He W; Li Z; Zhou F; Liu Z; Zhong G; Chen X; Zhao Y; Dong W; Huang J; Zheng J; Lin T
Int J Cancer; 2016 Jan; 138(1):74-86. PubMed ID: 26148677
[TBL] [Abstract][Full Text] [Related]
13. p53 overexpression represses androgen-mediated induction of NKX3.1 in a prostate cancer cell line.
Jiang A; Yu C; Zhang P; Chen W; Liu W; Hu X; Zhang J
Exp Mol Med; 2006 Dec; 38(6):625-33. PubMed ID: 17202838
[TBL] [Abstract][Full Text] [Related]
14. Structural and functional characterization of the 5' upstream promoter of the human Phox2a gene: possible direct transactivation by transcription factor Phox2b.
Hong SJ; Kim CH; Kim KS
J Neurochem; 2001 Dec; 79(6):1225-36. PubMed ID: 11752063
[TBL] [Abstract][Full Text] [Related]
15. The inhibitory effects of NKX3.1 on IGF-1R expression and its signalling pathway in human prostatic carcinoma PC3 cells.
Zhang PJ; Hu XY; Liu CY; Chen ZB; Ni NN; Yu Y; Yang LN; Huang ZQ; Liu QW; Jiang AL
Asian J Androl; 2012 May; 14(3):493-8. PubMed ID: 22179513
[TBL] [Abstract][Full Text] [Related]
16. E2F sites in the Op18 promoter are required for high level of expression in the human prostate carcinoma cell line PC-3-M.
Polzin RG; Benlhabib H; Trepel J; Herrera JE
Gene; 2004 Oct; 341():209-18. PubMed ID: 15474303
[TBL] [Abstract][Full Text] [Related]
17. Integration of regulatory networks by NKX3-1 promotes androgen-dependent prostate cancer survival.
Tan PY; Chang CW; Chng KR; Wansa KD; Sung WK; Cheung E
Mol Cell Biol; 2012 Jan; 32(2):399-414. PubMed ID: 22083957
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the role of Sp1 and NF-Y in differential regulation of PTTG/securin expression in tumor cells.
Clem AL; Hamid T; Kakar SS
Gene; 2003 Dec; 322():113-21. PubMed ID: 14644503
[TBL] [Abstract][Full Text] [Related]
19. Regulated expression of the TPĪ² isoform of the human T prostanoid receptor by the tumour suppressors FOXP1 and NKX3.1: Implications for the role of thromboxane in prostate cancer.
O'Sullivan AG; Eivers SB; Mulvaney EP; Kinsella BT
Biochim Biophys Acta Mol Basis Dis; 2017 Dec; 1863(12):3153-3169. PubMed ID: 28890397
[TBL] [Abstract][Full Text] [Related]
20. Transcriptional regulation of the mouse PNRC2 promoter by the nuclear factor Y (NFY) and E2F1.
Zhou D; Masri S; Ye JJ; Chen S
Gene; 2005 Nov; 361():89-100. PubMed ID: 16181749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
